Prospective, non-interventional, uncontrolled, open-chart, pharmacoepidemiologic study of prescribing patterns for anti-diabetic drugs at tertiary care hospital in Erode
DOI:
https://doi.org/10.22377/ijgp.v3i3.98Abstract
The aim of this study is to determine current prescribing patterns for anti-diabetic drugs adopted by physicians in Erode. Theprospective, non interventional, uncontrolled, open-chart, pharmacoepidemiological study was conducted from January -2007 to April -2007 at a diabetic care centre having 350 diabetic patients. The pattern of prescribing anti-diabetic drugs was recorded along with glycosylated haemoglobin levels, total cholesterol, high-density lipoprotein, low-density lipoprotein, very low-density lipoprotein and triglycerides in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus patients and the values were observed. The prescribing pattern of the oral anti-diabetic drugs shows that out of the various oral anti-diabetic drugs’ available, drugs from only two groups were prescribed. Sulphonylureas, biguanides and combination therapy accounts for 31.43%, 20.28% and 33.71% of prescriptions, respectively, while insulin alone and with OAD’s accounts for 6.28% and 8.29% prescriptions, respectively. Overall,
prescribing trend is away from monotherapy with insulin and sulphonylureas and towards combination therapies.
Key words: Diabetes mellitus, oral anti-diabetic drugs, demographic profile, pharmacoepidemiologic
Downloads
References
Kanugo A, Shatuvere A, Samalk. Antibodies to ICA 12 and
GAD65 in patients with NIDDM from Eastern India. Diabetologia
;4:164.
Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE.
Drug related admissions to an Australian Hospital. J Clin Pharm
Ther 1994;19:341-7.
Lesar T. S, Briceland L, Stein D. Factors related to errors in
medication prescribing. J Am Med Assoc 1997;277:341-7.
Skegg DC. Pit falls on pharmaco epidemiology. Br Med J
;32:1171-2.
Goyal P, Sharma G, Baljinderpal, Singh J, Singh J, Kaur Randhawa
G. Prospective, nonintervention, uncontrolled, open-chart,
pharmacoepidemiologic study of prescribing patterns for lipid
lowering drugs at a tertiary care teaching hospital in North India.
Clin Ther 2002;24:12.
Liesenfeld B, Heekeren H, Schade G, Hepp KD. Quality of
documentation in medical reports of diabetic patients. Int J Qual
Health Care 1996;8:537-42.
Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A.Evidence-based nutrition principles and recommendations for the
treatment and prevention of diabetes and related complications
Diabetes Care 2003;26:51.
World Health Organization. How to investigate drug use in Health
Facilities? Geneva, Switzerland: World Health Organization; 1993,
publication no: 1930049.
Don’t loss your nerves Dr. S. M. Sadikor Hon. Endocrinologists,
Jaslok Hospital and Research centre. Mumbai-26.
Wilkes E, Lawton EE. The Diabetic, The hospital and primary care.
J R Coll Gen Pract 1980;30:199-206.
Singh BM, Holland MR, Thorn PA. Metabolic control of diabetes
in general practice clinics: Comparison with a hospital clinic. Br
Med J 1984;289:726-8.
Lebovitz HE. Diabetes: Clinical science in practice. In: Leslie RD,
Robbins DC, editors. New York: Cambridge University Press; 1995.
p. 450-64.
Rockvile MD. Diabetes vital statistics. USA: American Diabetes
Association; 1996.
Harris MI. Diabetes in America National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases.
;2:95-1468.
Kadhe G, Arasan RE. Advances in drug delivery of oral
hypoglycemic agents Special section: Diabetes. Curr Sci
;83:1539-43.
Fulop M, Hoberman HD, Rascoff JH, Bonheim NA, Dreyer NP,
Tannenbaum H. Lactic acidosis in diabetic patients.Arch Intern
Med 1976;136:987.
Zermatten A, Heptner W, Delaloye B, Séchaud R, Felber JP.
Extrapancreatic effect of glibenclamide: stimulation of duodenal
insulin-releasing activity (DIRA) in man. Diabetologia 1977;13:85.
Diabetes control and complication trial research group. N Engl J
Med 1993;329:978-86.
Defronzo RA. Pharmacologic therapy for type 2 diabetes mellitus.
Ann Intern Med 1999;131:281-303.
Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes:
Scientific review. J Am Med Assoc 2002;287:360-72.
Cohen FJ, Neslusan CA, Conklin JE, Song X. Recent antihyperglycemic
prescribing trend for US privately insured patients
with Type 2 Diabetes. Niger J Clin Pract 2004;7:15-20.
Coulston AM, Mandelbaum D, Reaven GM. Dietary management
of nursing home residents with non-insulin-dependent diabetes
mellitus. Am J Clin Nutr 1990;51:67-71.
